TY - JOUR AU - Fitzmaurice, C. AU - Allen, C. AU - Barber, R. M. AU - Barregard, L. AU - Bhutta, Z. A. PY - 2017 DA - 2017// TI - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2016.5688 DO - 10.1001/jamaoncol.2016.5688 ID - Fitzmaurice2017 ER - TY - JOUR AU - Bauer, K. AU - Parise, C. AU - Caggiano, V. PY - 2010 DA - 2010// TI - Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen consensus statement for early breast cancer JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-228 DO - 10.1186/1471-2407-10-228 ID - Bauer2010 ER - TY - JOUR AU - Hudis, C. A. PY - 2007 DA - 2007// TI - Trastuzumab--mechanism of action and use in clinical practice JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMra043186 DO - 10.1056/NEJMra043186 ID - Hudis2007 ER - TY - JOUR AU - Luque-Cabal, M. AU - García-Teijido, P. AU - Fernández-Pérez, Y. AU - Sánchez-Lorenzo, L. AU - Palacio-Vázquez, I. PY - 2016 DA - 2016// TI - Mechanisms behind the resistance to trastuzumab in HER2-amplified breast cancer and strategies to overcome it JO - Clin Med Insights Oncol VL - 10 ID - Luque-Cabal2016 ER - TY - JOUR AU - Nakashoji, A. AU - Hayashida, T. AU - Yokoe, T. AU - Maeda, H. AU - Toyota, T. AU - Kikuchi, M. PY - 2018 DA - 2018// TI - The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer JO - Cancer Treat Rev VL - 62 UR - https://doi.org/10.1016/j.ctrv.2017.10.009 DO - 10.1016/j.ctrv.2017.10.009 ID - Nakashoji2018 ER - TY - JOUR AU - Carter, P. AU - Presta, L. AU - Gorman, C. M. AU - Ridgway, J. B. AU - Henner, D. AU - Wong, W. L. PY - 1992 DA - 1992// TI - Humanization of an anti-p185HER2 antibody for human cancer therapy JO - Proc Natl Acad Sci U S A VL - 89 UR - https://doi.org/10.1073/pnas.89.10.4285 DO - 10.1073/pnas.89.10.4285 ID - Carter1992 ER - TY - JOUR AU - Nahta, R. AU - Yu, D. AU - Hung, M. -. C. AU - Hortobagyi, G. N. AU - Esteva, F. J. PY - 2006 DA - 2006// TI - Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer JO - Nat Clin Pract Oncol VL - 3 UR - https://doi.org/10.1038/ncponc0509 DO - 10.1038/ncponc0509 ID - Nahta2006 ER - TY - JOUR AU - Scaltriti, M. AU - Rojo, F. AU - Ocaña, A. AU - Anido, J. AU - Guzman, M. AU - Cortes, J. PY - 2007 DA - 2007// TI - Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer JO - J Natl Cancer Inst VL - 99 UR - https://doi.org/10.1093/jnci/djk134 DO - 10.1093/jnci/djk134 ID - Scaltriti2007 ER - TY - JOUR AU - Esteller, M. PY - 2008 DA - 2008// TI - Epigenetics in Cancer JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMra072067 DO - 10.1056/NEJMra072067 ID - Esteller2008 ER - TY - JOUR AU - Paluszczak, J. AU - Baer-Dubowska, W. PY - 2006 DA - 2006// TI - Epigenetic diagnostics of cancer — the application of DNA methylation markers JO - J Appl Genet VL - 47 UR - https://doi.org/10.1007/BF03194647 DO - 10.1007/BF03194647 ID - Paluszczak2006 ER - TY - JOUR AU - Duffy, M. J. AU - Napieralski, R. AU - Martens, J. W. M. AU - Span, P. N. AU - Spyratos, F. AU - Sweep, F. C. G. J. PY - 2009 DA - 2009// TI - Methylated genes as new cancer biomarkers JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.12.008 DO - 10.1016/j.ejca.2008.12.008 ID - Duffy2009 ER - TY - JOUR AU - Rice, J. C. AU - Ozcelik, H. AU - Maxeiner, P. AU - Andrulis, I. AU - Futscher, B. W. PY - 2000 DA - 2000// TI - Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens JO - Carcinogenesis. VL - 21 UR - https://doi.org/10.1093/carcin/21.9.1761 DO - 10.1093/carcin/21.9.1761 ID - Rice2000 ER - TY - JOUR AU - Dammann, R. AU - Schagdarsurengin, U. AU - Strunnikova, M. AU - Rastetter, M. AU - Seidel, C. AU - Liu, L. PY - 2003 DA - 2003// TI - Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis JO - Histol Histopathol VL - 18 ID - Dammann2003 ER - TY - JOUR AU - Jones, P. A. PY - 2012 DA - 2012// TI - Functions of DNA methylation: islands, start sites, gene bodies and beyond JO - Nat Rev Genet VL - 13 UR - https://doi.org/10.1038/nrg3230 DO - 10.1038/nrg3230 ID - Jones2012 ER - TY - JOUR AU - Trempe, G. L. PY - 1976 DA - 1976// TI - Human breast cancer in culture JO - Recent Results Cancer Res VL - 57 ID - Trempe1976 ER - TY - JOUR AU - Blancafort, A. d. r. i. a. n. a. AU - Giró-Perafita, A. r. i. a. d. n. a. AU - Oliveras, G. l. ò. r. i. a. AU - Palomeras, S. ò. n. i. a. AU - Turrado, C. a. r. l. o. s. AU - Campuzano, Ò. s. c. a. r. AU - Carrión-Salip, D. o. l. o. r. s. AU - Massaguer, A. n. n. a. AU - Brugada, R. a. m. o. n. AU - Palafox, M. a. r. t. a. AU - Gómez-Miragaya, J. o. r. g. e. AU - González-Suárez, E. v. a. AU - Puig, T. e. r. e. s. a. PY - 2015 DA - 2015// TI - Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs JO - PLOS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0131241 DO - 10.1371/journal.pone.0131241 ID - Blancafort2015 ER - TY - JOUR AU - Puig, T. AU - Aguilar, H. AU - Cufí, S. AU - Oliveras, G. AU - Turrado, C. AU - Ortega-gutiérrez, S. PY - 2011 DA - 2011// TI - A novel inhibitor of fatty acid synthase shows activity against HER2 + breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3077 DO - 10.1186/bcr3077 ID - Puig2011 ER - TY - JOUR AU - Edge, S. B. AU - Compton, C. C. PY - 2010 DA - 2010// TI - The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer staging manual and the future of TNM JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-0985-4 DO - 10.1245/s10434-010-0985-4 ID - Edge2010 ER - TY - JOUR AU - Bender, C. M. AU - Pao, M. M. AU - Jones, P. A. PY - 1998 DA - 1998// TI - Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines JO - Cancer Res VL - 58 ID - Bender1998 ER - TY - JOUR AU - Sandoval, J. AU - Heyn, H. AU - Moran, S. AU - Serra-Musach, J. AU - Pujana, M. A. AU - Bibikova, M. PY - 2011 DA - 2011// TI - Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome JO - Epigenetics. VL - 6 UR - https://doi.org/10.4161/epi.6.6.16196 DO - 10.4161/epi.6.6.16196 ID - Sandoval2011 ER - TY - JOUR AU - Naumov, V. A. AU - Generozov, E. V. AU - Zaharjevskaya, N. B. AU - Matushkina, D. S. AU - Larin, A. K. AU - Chernyshov, S. V. PY - 2013 DA - 2013// TI - Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips JO - Epigenetics. VL - 8 UR - https://doi.org/10.4161/epi.25577 DO - 10.4161/epi.25577 ID - Naumov2013 ER - TY - JOUR AU - Ween, M. P. AU - Oehler, M. K. AU - Ricciardelli, C. PY - 2012 DA - 2012// TI - Transforming growth factor-beta-induced protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer JO - Int J Mol Sci VL - 13 UR - https://doi.org/10.3390/ijms130810461 DO - 10.3390/ijms130810461 ID - Ween2012 ER - TY - JOUR AU - Diaz-Lagares, A. AU - Crujeiras, A. B. AU - Lopez-Serra, P. AU - Soler, M. AU - Setien, F. AU - Goyal, A. PY - 2016 DA - 2016// TI - Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer JO - Proc Natl Acad Sci VL - 113 UR - https://doi.org/10.1073/pnas.1608585113 DO - 10.1073/pnas.1608585113 ID - Diaz-Lagares2016 ER - TY - JOUR AU - Diaz-Lagares, A. AU - Mendez-Gonzalez, J. AU - Hervas, D. AU - Saigi, M. AU - Pajares, M. J. AU - Garcia, D. PY - 2016 DA - 2016// TI - A novel epigenetic signature for early diagnosis in lung cancer JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2346 DO - 10.1158/1078-0432.CCR-15-2346 ID - Diaz-Lagares2016 ER - TY - JOUR AU - Wen, G. AU - Partridge, M. A. AU - Li, B. AU - Hong, M. AU - Liao, W. AU - Cheng, S. K. PY - 2011 DA - 2011// TI - TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells JO - Cancer Lett VL - 308 UR - https://doi.org/10.1016/j.canlet.2011.04.010 DO - 10.1016/j.canlet.2011.04.010 ID - Wen2011 ER - TY - JOUR AU - Kronski, E. AU - Fiori, M. E. AU - Barbieri, O. AU - Astigiano, S. AU - Mirisola, V. AU - Killian, P. H. PY - 2014 DA - 2014// TI - miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and −2 JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2014.01.005 DO - 10.1016/j.molonc.2014.01.005 ID - Kronski2014 ER - TY - JOUR AU - Wang, K. AU - Cao, F. AU - Fang, W. AU - Hu, Y. AU - Chen, Y. AU - Ding, H. PY - 2013 DA - 2013// TI - Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-343 DO - 10.1186/1471-2407-13-343 ID - Wang2013 ER - TY - JOUR AU - Dejeux, E. AU - Abdalaoui, H. AU - Gut, I. G. AU - Tost, J. PY - 2009 DA - 2009// TI - Identification and quantification of differentially methylated loci by the PyrosequencingTM technology JO - Methods Mol Biol VL - 507 UR - https://doi.org/10.1007/978-1-59745-522-0_15 DO - 10.1007/978-1-59745-522-0_15 ID - Dejeux2009 ER - TY - JOUR AU - Herman, J. G. AU - Graff, J. R. AU - Myohanen, S. AU - Nelkin, B. D. AU - Baylin, S. B. PY - 1996 DA - 1996// TI - Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands (DNA methylation/tumor suppressor genes/pl6/p15) JO - Proc Natl Acad Sci U S A VL - 93 UR - https://doi.org/10.1073/pnas.93.18.9821 DO - 10.1073/pnas.93.18.9821 ID - Herman1996 ER - TY - JOUR AU - Hashimoto, K. AU - Noshiro, M. AU - Ohno, S. AU - Kawamoto, T. AU - Satakeda, H. AU - Akagawa, Y. PY - 1997 DA - 1997// TI - Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen JO - Biochim Biophys Acta - Mol Cell Res VL - 1355 UR - https://doi.org/10.1016/S0167-4889(96)00147-4 DO - 10.1016/S0167-4889(96)00147-4 ID - Hashimoto1997 ER - TY - JOUR AU - Kim, J. -. E. AU - Jeong, H. -. W. AU - Nam, J. -. O. AU - Lee, B. -. H. AU - Choi, J. -. Y. AU - Park, R. -. W. PY - 2002 DA - 2002// TI - Identification of motifs in the fasciclin domains of the transforming growth factor-β-induced matrix protein βig-h3 that interact with the αvβ5 integrin JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M207055200 DO - 10.1074/jbc.M207055200 ID - Kim2002 ER - TY - JOUR AU - Billings, P. C. AU - Charles Whitbeck, J. AU - Adams, C. S. AU - Abrams, W. R. AU - Cohen, A. J. AU - Engelsberg, B. N. PY - 2002 DA - 2002// TI - The transforming growth factor-β-inducible matrix protein βig-h3 interacts with fibronectin JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M106837200 DO - 10.1074/jbc.M106837200 ID - Billings2002 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. AU - Shak, S. AU - Fuchs, H. AU - Paton, V. AU - Bajamonde, A. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - JOUR AU - Nahta, R. AU - Yuan, L. X. H. H. AU - Zhang, B. AU - Kobayashi, R. AU - Esteva, F. J. PY - 2005 DA - 2005// TI - Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3841 DO - 10.1158/0008-5472.CAN-04-3841 ID - Nahta2005 ER - TY - JOUR AU - Neve, R. M. AU - Chin, K. AU - Fridlyand, J. AU - Yeh, J. AU - Baehner, F. L. AU - Fevr, T. PY - 2006 DA - 2006// TI - A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes JO - Cancer Cell VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.10.008 DO - 10.1016/j.ccr.2006.10.008 ID - Neve2006 ER - TY - JOUR AU - Weigelt, B. AU - Lo, A. T. AU - Park, C. C. AU - Gray, J. W. AU - Bissell, M. J. PY - 2010 DA - 2010// TI - HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment JO - Breast Cancer Res Treat VL - 122 UR - https://doi.org/10.1007/s10549-009-0502-2 DO - 10.1007/s10549-009-0502-2 ID - Weigelt2010 ER - TY - JOUR AU - Shao, G. AU - Berenguer, J. AU - Borczuk, A. C. AU - Powell, C. A. AU - Hei, T. K. AU - Zhao, Y. PY - 2006 DA - 2006// TI - Epigenetic inactivation of Betaig-h3 gene in human cancer cells JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-2130 DO - 10.1158/0008-5472.CAN-05-2130 ID - Shao2006 ER - TY - JOUR AU - Wang, N. AU - Zhang, H. AU - Yao, Q. AU - Wang, Y. AU - Dai, S. AU - Yang, X. PY - 2012 DA - 2012// TI - TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer JO - J Exp Clin Cancer Res VL - 31 UR - https://doi.org/10.1186/1756-9966-31-6 DO - 10.1186/1756-9966-31-6 ID - Wang2012 ER - TY - JOUR AU - Skonier, J. AU - Neubauer, M. AU - Madisen, L. AU - Bennett, K. AU - Plowman, G. D. AU - Purchio, A. F. PY - 1992 DA - 1992// TI - cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β JO - DNA Cell Biol VL - 11 UR - https://doi.org/10.1089/dna.1992.11.511 DO - 10.1089/dna.1992.11.511 ID - Skonier1992 ER - TY - JOUR AU - Calaf, G. M. AU - Echiburú-Chau, C. AU - Zhao, Y. L. AU - Hei, T. K. PY - 2008 DA - 2008// TI - BigH3 protein expression as a marker for breast cancer JO - Int J Mol Med VL - 21 ID - Calaf2008 ER - TY - JOUR AU - Shah, J. N. AU - Shao, G. AU - Hei, T. K. AU - Zhao, Y. PY - 2008 DA - 2008// TI - Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR JO - BMC Cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-284 DO - 10.1186/1471-2407-8-284 ID - Shah2008 ER - TY - JOUR AU - Ahmed, A. A. AU - Mills, A. D. AU - Ibrahim, A. E. K. K. AU - Temple, J. AU - Blenkiron, C. AU - Vias, M. PY - 2007 DA - 2007// TI - The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel JO - Cancer Cell VL - 12 UR - https://doi.org/10.1016/j.ccr.2007.11.014 DO - 10.1016/j.ccr.2007.11.014 ID - Ahmed2007 ER - TY - JOUR AU - Kitahara, O. AU - Furukawa, Y. AU - Tanaka, T. AU - Kihara, C. AU - Ono, K. AU - Yanagawa, R. PY - 2001 DA - 2001// TI - Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia JO - Cancer Res VL - 61 ID - Kitahara2001 ER - TY - JOUR AU - Schneider, D. AU - Kleeff, J. AU - Berberat, P. O. AU - Zhu, Z. AU - Korc, M. AU - Friess, H. PY - 2002 DA - 2002// TI - Induction and expression of betaig-h3 in pancreatic cancer cells JO - Biochim Biophys Acta VL - 1588 UR - https://doi.org/10.1016/S0925-4439(02)00052-2 DO - 10.1016/S0925-4439(02)00052-2 ID - Schneider2002 ER - TY - JOUR AU - Guo, S. -. K. AU - Shen, M. -. F. AU - Yao, H. -. W. AU - Liu, Y. -. S. PY - 2018 DA - 2018// TI - Enhanced expression of TGFBI promotes the proliferation and migration of glioma cells JO - Cell Physiol Biochem VL - 49 UR - https://doi.org/10.1159/000493293 DO - 10.1159/000493293 ID - Guo2018 ER - TY - JOUR AU - Chen, W. -. Y. AU - Tsai, Y. -. C. AU - Yeh, H. -. L. AU - Suau, F. AU - Jiang, K. -. C. AU - Shao, A. -. N. PY - 2017 DA - 2017// TI - Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer JO - Sci Signal VL - 10 UR - https://doi.org/10.1126/scisignal.aam6826 DO - 10.1126/scisignal.aam6826 ID - Chen2017 ER - TY - JOUR AU - Desgrosellier, J. S. AU - Cheresh, D. A. PY - 2010 DA - 2010// TI - Integrins in cancer: biological implications and therapeutic opportunities JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2748 DO - 10.1038/nrc2748 ID - Desgrosellier2010 ER - TY - JOUR AU - Soung, Y. H. AU - Clifford, J. L. AU - Chung, J. PY - 2010 DA - 2010// TI - Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression JO - BMB Rep VL - 43 UR - https://doi.org/10.5483/BMBRep.2010.43.5.311 DO - 10.5483/BMBRep.2010.43.5.311 ID - Soung2010 ER - TY - JOUR AU - Lesniak, D. AU - Xu, Y. AU - Deschenes, J. AU - Lai, R. AU - Thoms, J. AU - Murray, D. PY - 2009 DA - 2009// TI - 1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1591 DO - 10.1158/0008-5472.CAN-09-1591 ID - Lesniak2009 ER - TY - JOUR AU - Guo, W. AU - Pylayeva, Y. AU - Pepe, A. AU - Yoshioka, T. AU - Muller, W. J. AU - Inghirami, G. PY - 2006 DA - 2006// TI - β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis JO - Cell. VL - 126 UR - https://doi.org/10.1016/j.cell.2006.05.047 DO - 10.1016/j.cell.2006.05.047 ID - Guo2006 ER - TY - JOUR AU - Nam, J. -. O. AU - Jeong, H. -. W. AU - Lee, B. -. H. AU - Park, R. -. W. AU - Kim, I. -. S. PY - 2005 DA - 2005// TI - Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of βig-h3, via αvβ3 integrin JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-2705 DO - 10.1158/0008-5472.CAN-04-2705 ID - Nam2005 ER - TY - JOUR AU - Zhao, Y. L. AU - Piao, C. Q. AU - Hei, T. K. PY - 2002 DA - 2002// TI - Overexpression of Betaig-h3 gene downregulates integrin alpha5beta1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells JO - Br J Cancer VL - 86 UR - https://doi.org/10.1038/sj.bjc.6600304 DO - 10.1038/sj.bjc.6600304 ID - Zhao2002 ER - TY - JOUR AU - Kim, J. -. E. AU - Kim, S. -. J. AU - Jeong, H. -. W. AU - Lee, B. -. H. AU - Choi, J. -. Y. AU - Park, R. -. W. PY - 2003 DA - 2003// TI - RGD peptides released from βig-h3, a TGF-β-induced cell-adhesive molecule, mediate apoptosis JO - Oncogene. VL - 22 UR - https://doi.org/10.1038/sj.onc.1206269 DO - 10.1038/sj.onc.1206269 ID - Kim2003 ER - TY - JOUR AU - Wen, G. AU - Hong, M. AU - Li, B. AU - Liao, W. AU - Cheng, S. K. AU - Hu, B. PY - 2011 DA - 2011// TI - Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway JO - Int J Oncol VL - 39 ID - Wen2011 ER - TY - JOUR AU - Becker, J. AU - Volland, S. AU - Noskova, I. AU - Schramm, A. AU - Schweigerer, L. L. AU - Wilting, J. PY - 2008 DA - 2008// TI - Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion JO - Int J Oncol VL - 32 ID - Becker2008 ER - TY - JOUR AU - Bissey, P. -. A. AU - Law, J. H. AU - Bruce, J. P. AU - Shi, W. AU - Renoult, A. AU - Chua, M. L. K. PY - 2018 DA - 2018// TI - Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma JO - Oncogenesis. VL - 7 UR - https://doi.org/10.1038/s41389-018-0050-x DO - 10.1038/s41389-018-0050-x ID - Bissey2018 ER - TY - JOUR AU - Beyer, I. AU - Li, Z. AU - Persson, J. AU - Liu, Y. AU - Rensburg, R. AU - Yumul, R. PY - 2011 DA - 2011// TI - Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2010.256 DO - 10.1038/mt.2010.256 ID - Beyer2011 ER - TY - JOUR AU - Pajares, M. J. AU - Agorreta, J. AU - Salvo, E. AU - Behrens, C. AU - Wistuba, I. I. AU - Montuenga, L. M. PY - 2014 DA - 2014// TI - TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2014.33 DO - 10.1038/bjc.2014.33 ID - Pajares2014 ER - TY - JOUR AU - Schettini, F. AU - Buono, G. AU - Cardalesi, C. AU - Desideri, I. AU - Placido, S. AU - Mastro, L. PY - 2016 DA - 2016// TI - Hormone receptor/human epidermal growth factor receptor 2-positive breast cancer: where we are now and where we are going JO - Cancer Treat Rev VL - 46 UR - https://doi.org/10.1016/j.ctrv.2016.03.012 DO - 10.1016/j.ctrv.2016.03.012 ID - Schettini2016 ER - TY - JOUR AU - Gianni, L. AU - Pienkowski, T. AU - Im, Y. -. H. AU - Tseng, L. -. M. AU - Liu, M. -. C. AU - Lluch, A. PY - 2016 DA - 2016// TI - 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)00163-7 DO - 10.1016/S1470-2045(16)00163-7 ID - Gianni2016 ER -